Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Anthera Pharmaceuticals Company Profile (NASDAQ:ANTH)

Consensus Ratings for Anthera Pharmaceuticals (NASDAQ:ANTH) (?)
Ratings Breakdown: 1 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $3.90 (22.77% downside)

Analysts' Ratings History for Anthera Pharmaceuticals (NASDAQ:ANTH)
Show:
DateFirmActionRatingPrice TargetDetailsShare
2/12/2015ZacksDowngradeOutperform -> Neutral$3.90ViewTweet This Rating  Share This Rating on StockTwits
1/14/2015ZacksUpgradeNeutral -> Outperform$2.70ViewTweet This Rating  Share This Rating on StockTwits
9/30/2014ZacksDowngradeOutperform -> Neutral$2.10ViewTweet This Rating  Share This Rating on StockTwits
3/28/2013MLV & Co Lower Price TargetBuy$4.50 -> $2.00ViewTweet This Rating  Share This Rating on StockTwits
3/5/2013Jefferies GroupInitiated CoverageBuy$2.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 2/27/2013 forward)